These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4472091)

  • 1. Effect of DDS therapy on the acetylcholine sweat function test in fifty cases of tuberculoid and maculoanesthetic leprosy.
    Yawalkar SJ; Sanjana HB
    Int J Lepr Other Mycobact Dis; 1974; 42(1):55-7. PubMed ID: 4472091
    [No Abstract]   [Full Text] [Related]  

  • 2. Dapsone in wheat flour as a possible method of therapy in leprosy. A laboratory report.
    Naik SS; Pandya SS
    Lepr India; 1977 Oct; 49(4):516-20. PubMed ID: 604659
    [No Abstract]   [Full Text] [Related]  

  • 3. Six cases of dapsone-resistant tuberculoid leprosy.
    Pearson JM; Kiran KU; Stanley JN
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):534-5. PubMed ID: 6399070
    [No Abstract]   [Full Text] [Related]  

  • 4. Operational study to monitor the regularity of dapsone intake by leprosy out-patients.
    Kumar A; Balakrishnan S
    Lepr India; 1983 Jul; 55(3):521-7. PubMed ID: 6656209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring the regularity of self administration of dapsone by leprosy patients.
    Kumar A; Balakrishnan S
    Lepr India; 1982 Oct; 54(4):664-70. PubMed ID: 7183832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dapsone on blood lactic and pyruvic acids in leprosy.
    Sinha SN; Gupta SC; Bajaj AK; Srivastava NP; Mehrotra TN
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):468-70. PubMed ID: 6892022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of long-term domiciliary dapsone (DDS) monotherapy for lepromatous leprosy in Gudiyatham Taluk, South India.
    Almeida JG; Christian M; Chacko CJ
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):385-6. PubMed ID: 6685703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the self administration of DDS in Gudiyatham Taluk.
    Jesudasan K; George B; Chacko CJ; Taylor PM; Kurian PV; Job CK
    Lepr India; 1976 Oct; 48(4 Suppl):668-76. PubMed ID: 1026802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to dapsone (DDS) monotherapy in leprosy patients of Gudiyatham Taluk, South India: comparison between the 1960s and the 1970s.
    Almeida JG; Christian M; Chacko CJ
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):378-8. PubMed ID: 6685701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regularity of dapsone intake by leprosy patients attending urban treatment centre.
    Naik SS; Ganapati R
    Lepr India; 1977 Apr; 49(2):207-15. PubMed ID: 909287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between regularity in dapsone (DDS) treatment and development of deformity.
    Radhakrishna S; Nair NG
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):425-34. PubMed ID: 3655458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
    Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ
    Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585
    [No Abstract]   [Full Text] [Related]  

  • 15. DDS 100 mg daily, the cornerstone in the management of reversal reaction.
    van der Meulen J; Mock B
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):457-9. PubMed ID: 7200466
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDS chemoprophylaxis for leprosy in children at Culion Sanitarium Palawan, Philippines.
    Lara CB
    Acta Leprol; 1978; (70):35-58. PubMed ID: 104537
    [No Abstract]   [Full Text] [Related]  

  • 18. Dapsone levels after oral therapy and weekly oily injections in Ethiopian leprosy patients.
    Modderman ES; Merkus FW; Zuidema J; Hilbers HW; Warndorff T
    Int J Lepr Other Mycobact Dis; 1983 Jun; 51(2):191-6. PubMed ID: 6684645
    [No Abstract]   [Full Text] [Related]  

  • 19. DDS-resistant infection among leprosy patients in the population of Gudiyatham Taluk, South India. Part 3. Prevalence, incidence, risk factors, and interpretation of mouse foot pad test results.
    Almeida JG; Chacko CJ; Christian M; Taylor PM; Fritschi EP
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):366-73. PubMed ID: 6685699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Dapsone in chemotherapy of leprosy--a comparison of responses to therapy in two cohorts in 1960s and 1970s.
    Reddy BN; Neelan PN
    Indian J Lepr; 1984; 56(4):912-8. PubMed ID: 6398345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.